COVID-19 vaccination in the Gaza Strip: a cross-sectional study of vaccine coverage, hesitancy, and associated risk factors among community members and healthcare workers.

COVID-19 Gaza Strip Healthcare workers Hesitancy Humanitarian settings Palestine Vaccine

Journal

Conflict and health
ISSN: 1752-1505
Titre abrégé: Confl Health
Pays: England
ID NLM: 101286573

Informations de publication

Date de publication:
09 Sep 2022
Historique:
received: 10 03 2022
accepted: 06 08 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 10 9 2022
Statut: epublish

Résumé

The Gaza Strip, like other settings of complex humanitarian emergencies, faces immense challenges in vaccinating its population against COVID-19. This study was conducted in October 2021 among Gaza's adult population and healthcare workers (HCWs). The primary aim was to estimate two indicators, coverage of COVID-19 vaccination and the prevalence of vaccine hesitancy. The secondary aim was to evaluate the two indicators' associations with globally identified risk factors. A cross-sectional study was conducted using a population-based survey of adults and a purposive survey of HCWs in Gaza. A multi-stage sampling design was used for the population survey component. For the HCW component, five health facilities were purposively selected as entry points; HCWs in the facilities holding clinical or other specialized positions were approached to participate in the survey. Data were summarized as univariable descriptive statistics with unweighted and weighted point estimates. Logistic regression was used to evaluate associations of risk factors with vaccination status and vaccine hesitancy. A total of 1075 individuals were surveyed, of whom 906 were community members and 169 were HCWs. Population-weighted vaccine coverage was estimated to be 49.08% (95% CI 43.10-55.08). 89.35% of HCWs were vaccinated. Population-weighted vaccine hesitancy was estimated to be 34.08% (95% CI 28.14-40.56) in the overall population and 67.24% (95% CI 49.04-81.41) among the unvaccinated sub-group. In logistic regression vaccination was independently associated with male sex (aOR 1.88, p = 0.006, 95% CI 1.20-2.95), older age (40+ vs. 18-39 age group) (aOR 1.92, p < 0.001, 95% CI 1.73-2.13), higher education (aOR 2.19, p < 0.001, 95% CI 1.51-3.17), and confidence in the safety of the vaccine (aOR 13.8, p < 0.001, 95% CI 10.1-18.8). Risk factors for hesitancy were similar to those identified for vaccination status, however hesitant individuals were somewhat more likely to obtain vaccine information from family members (aOR 1.29, p = 0.051, 95% CI 1.00-1.67) and less likely to trust healthcare providers (aOR 0.58, p < 0.001, 95% CI 0.49-0.68). The continued emergence of SARS-CoV-2 variants reinforces the importance of achieving high levels of vaccination coverage globally-a difficult undertaking in Gaza. This study estimated half of Gaza's adult population received at least one dose of any COVID-19 vaccine by October 2021, and the majority of unvaccinated individuals were hesitant. Disparities in vaccination across the territory's demographic groups underscore the need for targeted outreach to these populations and messaging through community-based channels to permeate social networks of the unvaccinated.

Sections du résumé

BACKGROUND BACKGROUND
The Gaza Strip, like other settings of complex humanitarian emergencies, faces immense challenges in vaccinating its population against COVID-19. This study was conducted in October 2021 among Gaza's adult population and healthcare workers (HCWs). The primary aim was to estimate two indicators, coverage of COVID-19 vaccination and the prevalence of vaccine hesitancy. The secondary aim was to evaluate the two indicators' associations with globally identified risk factors.
METHODS METHODS
A cross-sectional study was conducted using a population-based survey of adults and a purposive survey of HCWs in Gaza. A multi-stage sampling design was used for the population survey component. For the HCW component, five health facilities were purposively selected as entry points; HCWs in the facilities holding clinical or other specialized positions were approached to participate in the survey. Data were summarized as univariable descriptive statistics with unweighted and weighted point estimates. Logistic regression was used to evaluate associations of risk factors with vaccination status and vaccine hesitancy.
RESULTS RESULTS
A total of 1075 individuals were surveyed, of whom 906 were community members and 169 were HCWs. Population-weighted vaccine coverage was estimated to be 49.08% (95% CI 43.10-55.08). 89.35% of HCWs were vaccinated. Population-weighted vaccine hesitancy was estimated to be 34.08% (95% CI 28.14-40.56) in the overall population and 67.24% (95% CI 49.04-81.41) among the unvaccinated sub-group. In logistic regression vaccination was independently associated with male sex (aOR 1.88, p = 0.006, 95% CI 1.20-2.95), older age (40+ vs. 18-39 age group) (aOR 1.92, p < 0.001, 95% CI 1.73-2.13), higher education (aOR 2.19, p < 0.001, 95% CI 1.51-3.17), and confidence in the safety of the vaccine (aOR 13.8, p < 0.001, 95% CI 10.1-18.8). Risk factors for hesitancy were similar to those identified for vaccination status, however hesitant individuals were somewhat more likely to obtain vaccine information from family members (aOR 1.29, p = 0.051, 95% CI 1.00-1.67) and less likely to trust healthcare providers (aOR 0.58, p < 0.001, 95% CI 0.49-0.68).
CONCLUSIONS CONCLUSIONS
The continued emergence of SARS-CoV-2 variants reinforces the importance of achieving high levels of vaccination coverage globally-a difficult undertaking in Gaza. This study estimated half of Gaza's adult population received at least one dose of any COVID-19 vaccine by October 2021, and the majority of unvaccinated individuals were hesitant. Disparities in vaccination across the territory's demographic groups underscore the need for targeted outreach to these populations and messaging through community-based channels to permeate social networks of the unvaccinated.

Identifiants

pubmed: 36085165
doi: 10.1186/s13031-022-00477-7
pii: 10.1186/s13031-022-00477-7
pmc: PMC9461392
doi:

Types de publication

Journal Article

Langues

eng

Pagination

48

Informations de copyright

© 2022. The Author(s).

Références

J Occup Environ Med. 2021 Oct 1;63(10):852-856
pubmed: 34138823
Elife. 2021 May 27;10:
pubmed: 34042047
Vaccines (Basel). 2021 Jan 12;9(1):
pubmed: 33445581
Int J Infect Dis. 2022 Jun;119:53-55
pubmed: 35346835
Lancet. 2021 Jun 26;397(10293):2447-2449
pubmed: 34118998
Vaccines (Basel). 2022 Jan 24;10(2):
pubmed: 35214638
Vaccines (Basel). 2022 Jun 10;10(6):
pubmed: 35746539
Nat Med. 2021 May;27(5):747-749
pubmed: 33875889
Int J Equity Health. 2022 Jun 11;21(1):82
pubmed: 35701823
BMJ Open. 2021 Oct 7;11(10):e053681
pubmed: 34620671
Vaccines (Basel). 2021 Jul 29;9(8):
pubmed: 34451960
Brain Behav Immun. 2021 May;94:41-50
pubmed: 33713824
Curr Opin Infect Dis. 2021 Oct 1;34(5):519-526
pubmed: 34524202
Health Policy Technol. 2022 Jun;11(2):100584
pubmed: 34868834
Int J Environ Res Public Health. 2021 Aug 22;18(16):
pubmed: 34444585
Lancet Rheumatol. 2022 Mar;4(3):e160-e163
pubmed: 34927089
Vaccines (Basel). 2021 Mar 22;9(3):
pubmed: 33810131
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Lancet Infect Dis. 2022 Sep;22(9):1293-1302
pubmed: 35753318
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Vaccines (Basel). 2021 Oct 25;9(11):
pubmed: 34835174
Lancet Reg Health Eur. 2022 Jan;12:100289
pubmed: 34927116
Nat Hum Behav. 2021 Jul;5(7):947-953
pubmed: 33972767

Auteurs

Jennifer Majer (J)

International Programs Department, International Medical Corps, Los Angeles, CA, USA. jlmajer@internationalmedicalcorps.org.

Jehad H Elhissi (JH)

Department of Medicine, Al-Azhar University, Gaza City, Palestine.

Nabil Mousa (N)

Programs Department, International Medical Corps, Gaza City, Palestine.

Natalya Kostandova (N)

International Programs Department, International Medical Corps, Los Angeles, CA, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Classifications MeSH